Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 6, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 15
- −1 vs. Q1 2026
- Portfolio value
- $798.7M
- +$146.3M (+22.4%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $300.2M | 37.6% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $212.0M | 26.5% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $89.7M | 11.2% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 1,784,517 | $74.4M | 9.3% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 1,979,173 | $32.4M | 4.1% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $23.5M | 2.9% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 4,024,861 | $20.7M | 2.6% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $12.0M | 1.5% | 00.0% | Unchanged | History |
| CBRSCerebras Systems Inc. | COM CL A | 53,586 | $11.8M | 1.5% | +53,586 | New | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $9.12M | 1.1% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $8.08M | 1.0% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $3.14M | 0.4% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM NEW | 53,732 | $989.2K | 0.1% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 311,967 | $256.7K | <0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM NEW | 22,779 | $196.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (2)
Positions held at the end of Q1 2026 that are gone from this filing.